Toward Clinical Implementation of Polygenic Scores for Substance Use Disorders: A Multi-Ancestry Study
PGS demonstrated clinically meaningful risk prediction for substance use disorders in EA and LA, supporting the feasibility of future clinical implementation for population-level screening and underscoring the urgent need for more genetic studies in that population.